Although we did not assess TLR4 expression directly, prior studies suggest that oral epithelial and carcinoma cells can express functional TLR4 under inflammatory conditions, which may contribute to LPS responsiveness [44, 45]. The gene discussed is TLR4; the disease is carcinoma.